Mezzion Pharma Co 주식 주식분석 | 주식가격 | 뉴스 | 140410.KQ | KR7140410002 | | 2025년 7월

날짜	Mezzion Pharma Co 주식 가격
	39,450.00 undefined
	39,250.00 undefined
	39,000.00 undefined
	39,500.00 undefined
	40,900.00 undefined
	37,950.00 undefined
	37,050.00 undefined
	36,700.00 undefined
	36,650.00 undefined
	36,650.00 undefined
	37,000.00 undefined
	36,600.00 undefined
	37,450.00 undefined
	38,100.00 undefined
	38,800.00 undefined
	37,800.00 undefined
	37,650.00 undefined
	38,050.00 undefined
	38,150.00 undefined
	38,400.00 undefined
	39,850.00 undefined

날짜	Mezzion Pharma Co 매출	Mezzion Pharma Co EBIT	Mezzion Pharma Co 이익
2024	8.61 조. undefined	-14.3 조. undefined	-19.48 조. undefined
2023	31.72 조. undefined	-14.49 조. undefined	-12.73 조. undefined
2022	30.73 조. undefined	-23.33 조. undefined	-36.3 조. undefined
2021	26.65 조. undefined	-16.8 조. undefined	-13.6 조. undefined
2020	28.63 조. undefined	-7.53 조. undefined	-13.83 조. undefined
2019	17.92 조. undefined	-24.72 조. undefined	-23.25 조. undefined
2018	19.09 조. undefined	-21.93 조. undefined	-18.88 조. undefined
2017	5.59 조. undefined	-16.85 조. undefined	-14.88 조. undefined
2016	8.75 조. undefined	-7.22 조. undefined	-12.99 조. undefined
2015	14.93 조. undefined	-2.73 조. undefined	4.22 조. undefined
2014	4.86 조. undefined	-4.92 조. undefined	-2.57 조. undefined
2013	4.4 조. undefined	-2.47 조. undefined	-831 백만 undefined
2012	8.59 조. undefined	1.68 조. undefined	2.39 조. undefined
2011	5.07 조. undefined	2.93 조. undefined	3.2 조. undefined
2010	24.25 조. undefined	17.64 조. undefined	17.07 조. undefined
2009	18.44 조. undefined	12.97 조. undefined	11.57 조. undefined
2008	206 백만 undefined	-2.66 조. undefined	-2.23 조. undefined

	매출	EBIT	이익
2008	206 백만 KRW	-2.66 조. KRW	-2.23 조. KRW
2009	18.44 조. KRW	12.97 조. KRW	11.57 조. KRW
2010	24.25 조. KRW	17.64 조. KRW	17.07 조. KRW
2011	5.07 조. KRW	2.93 조. KRW	3.2 조. KRW
2012	8.59 조. KRW	1.68 조. KRW	2.39 조. KRW
2013	4.4 조. KRW	-2.47 조. KRW	-831 백만 KRW
2014	4.86 조. KRW	-4.92 조. KRW	-2.57 조. KRW
2015	14.93 조. KRW	-2.73 조. KRW	4.22 조. KRW
2016	8.75 조. KRW	-7.22 조. KRW	-12.99 조. KRW
2017	5.59 조. KRW	-16.85 조. KRW	-14.88 조. KRW
2018	19.09 조. KRW	-21.93 조. KRW	-18.88 조. KRW
2019	17.92 조. KRW	-24.72 조. KRW	-23.25 조. KRW
2020	28.63 조. KRW	-7.53 조. KRW	-13.83 조. KRW
2021	26.65 조. KRW	-16.8 조. KRW	-13.6 조. KRW
2022	30.73 조. KRW	-23.33 조. KRW	-36.3 조. KRW
2023	31.72 조. KRW	-14.49 조. KRW	-12.73 조. KRW
2024	8.61 조. KRW	-14.3 조. KRW	-19.48 조. KRW

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
0.21	18.44	24.25	5.07	8.59	4.4	4.86	14.93	8.75	5.59	19.09	17.92	28.63	26.65	30.73	31.72	8.61
-	8,852.91	31.50	-79.11	69.57	-48.77	10.34	207.31	-41.37	-36.17	241.71	-6.12	59.79	-6.92	15.28	3.24	-72.85
927.18	10.36	7.88	100.00	74.30	56.72	50.28	65.85	56.72	16.09	16.96	16.19	25.98	13.87	-1.02	12.24	22.18
0	0	0	5.07	6.38	2.5	2.44	9.83	4.96	0.9	3.24	2.9	7.44	3.7	-0.31	3.88	1.91
-2.23	11.57	17.07	3.2	2.39	-0.83	-2.57	4.22	-12.99	-14.88	-18.88	-23.25	-13.83	-13.6	-36.3	-12.73	-19.48
-	-619.02	47.58	-81.23	-25.56	-134.84	209.03	-264.45	-407.48	14.61	26.84	23.18	-40.52	-1.64	166.85	-64.93	53.02
8	8	8	6	8	7	8	8	7	7	8	9	9	26.69	26.73	28.24	29.82
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

0.9	6.71	20.29	17.65	59.57	54.43	68.59	93.17	89.06	61.76	55.07	41.16	49.1	47.21	32.4	58.25	28.62
0.23	0.59	0.14	0.35	0	1.41	1.86	1.56	1.5	1.8	2.03	3.03	2.62	2.46	2.68	2.65	1.14
0.03	0.09	0	0	0	1.94	0.7	0.48	0.97	0.29	4.59	1.37	1.63	2.13	1.69	3.38	0.61
0	0	0	0	0	0.46	2.27	2.05	2.41	2.74	2.4	6	7.01	11.78	8.83	5.74	5.42
0.02	0.53	0	0.19	0	0	0.09	0.08	0.27	3.91	5.93	0.29	0.31	0.6	0.3	4.22	6.13
1.17	7.92	20.43	18.19	59.57	58.24	73.51	97.33	94.19	70.5	70.02	51.85	60.67	64.17	45.9	74.24	41.93
0.21	0.12	0.13	0.17	0.18	0.14	0.32	0.75	0.2	0.86	1.2	4.9	5.9	4.88	4.24	2.85	2.53
0	4.99	9.52	10.65	5.68	3.06	0	2.02	0	0	0	0	0	-0	-0	0	-0
0	0	0	0	0	0	263	293	332	487	223	30	160	30	310	150	280
0	0	0.82	0.98	1.08	1.08	2.32	1.83	0.31	1.64	1.64	1.62	8.24	14.18	1.62	12.94	28.44
0	0	0	0	0	0	705	705	0	0	0	0	0	0	0	0	0
0.15	1.84	0.66	1.59	0.78	0.81	0.76	0.14	0.86	0.55	1.98	0.47	0.66	0.67	1.95	1.96	0.82
0.36	6.95	11.14	13.39	7.73	5.1	4.37	5.72	1.71	3.54	5.04	7.02	14.96	19.76	8.12	17.91	32.07
1.53	14.86	31.57	31.58	67.3	63.34	77.87	103.05	95.9	74.04	75.06	58.87	75.63	83.93	54.02	92.15	74

1.53	3.03	3.03	3.03	4.04	4.04	4.06	4.08	4.08	4.17	4.32	4.35	4.45	4.45	13.37	14.8	14.98
5.45	5.44	5.44	5.44	51.33	51.62	53.03	52.51	54.8	63.37	64.14	67.28	92.84	88.25	79.7	130.96	139.51
-11.72	-0.15	16.32	19.62	21.69	20.5	17.83	21.86	9.91	-5.13	-24.11	-47.35	-61.17	-74.79	-111.05	-123.72	-143.15
0	0	0.04	0.08	-13.73	0.02	0	0.91	0.83	-0.54	14.22	18.55	20.69	44.88	44.22	39.41	34.72
0	-73	0	0	0	0	0	0	8	0	0	0	0	0	0	0	0
-4.74	8.25	24.83	28.17	63.34	76.18	74.91	79.35	69.63	61.88	58.56	42.83	56.81	62.79	26.24	61.44	46.06
0	0	0	0	0.69	0	0.01	2.24	3.44	2.47	2.99	3.57	3.47	5.5	7.17	4.03	1.65
0.1	0.24	0.17	0.1	0	0.08	0.28	0.12	0.84	4.92	7.64	7.85	5.53	7.19	11.47	21.83	18.88
0.57	2.34	4.32	1.27	2.26	0.06	10.42	11.35	12.2	4.93	6.87	0.91	4.52	3.82	5.35	2.52	5.45
1.5	0	0	0	0	0	0	0	0	0	0	0.43	0.99	0.93	1.06	0.5	0
0	0	0	0	0	0	0	0	0	8.18	0.24	0.75	1.02	1.05	1.03	0.74	0.69
2.16	2.59	4.49	1.36	2.95	0.14	10.7	13.72	16.48	20.49	17.74	13.51	15.51	18.5	26.08	29.62	26.67
0	0	0	0	0	0	0	25.24	26.26	0	0	2.42	3.1	2.34	1.62	1.01	0.92
0	0	0	0	0	0	0	147	354	376	0	0	0	0	0	0	251.42
4.1	4.03	2.25	2.05	1.02	1.03	1.02	1.41	0	0	0	0.11	0.2	0.31	0.08	0.08	0.09
4.1	4.03	2.25	2.05	1.02	1.03	1.02	26.8	26.61	0.38	0	2.53	3.3	2.64	1.7	1.09	1.26
6.27	6.61	6.74	3.41	3.97	1.16	11.72	40.52	43.09	20.87	17.74	16.04	18.82	21.14	27.78	30.7	27.94
1.53	14.86	31.57	31.58	67.3	77.34	86.64	119.87	112.72	82.75	76.3	58.88	75.63	83.93	54.02	92.15	74

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
-2.23	11.57	20.16	4.09	3	-0.52	-3.33	5.16	-12.99	-14.88	-18.88	-23.25	-13.83	-13.51	-36.3
0.07	0.1	0.1	0.04	0.05	0.05	0.15	0.34	0.41	0.06	0.23	1.33	1.43	1.59	1.66
0	-1,410	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.17	0.6	-2.68	-3.09	1.9	-1.71	0.1	3.91	1.2	3.53	-1.43	-1.95	-2.93	-2.41	6.22
0.01	0.9	-0.5	-2.56	-1.81	-1.37	-1.42	-7.64	5.3	-1.93	-1.65	2.99	7.95	-0.74	16.35
0	0	0	0	0	0	0	0	547	478	375	878	9	7	26
0	0	0.72	3.12	0.22	0.81	-0.56	-0.06	-0.01	-0.19	0.22	2.28	0.13	1.53	0.4
-2.32	11.75	17.08	-1.52	3.14	-3.56	-4.5	1.77	-6.08	-13.21	-21.72	-20.88	-7.38	-15.07	-12.07
-180	-779	-25	-318	-165	-7	-251	-564	-169	-2,048	-572	-1,098	-7,956	-6,182	-1,761
-0.16	-5.93	-11.56	0.73	-26.57	13.62	-2.48	-0.98	-36.81	36.42	1.29	0.3	3.56	-16.33	17.41
0.02	-5.15	-11.53	1.04	-26.4	13.62	-2.23	-0.41	-36.64	38.47	1.86	1.4	11.52	-10.15	19.17
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	-1.5	0	0	0	0	0	42	-1.8	-23.7	-3.19	-1.04	22.99	-1.11	-0.93
0	1.49	0	0	32.9	0	6.9	-7.65	0	12.45	21.25	7.81	1.02	0.23	0.31
0	-0.01	0	0	32.9	-0.18	16.3	24.95	-1.8	-11.25	18.06	6.76	24.01	19.11	-0.62
0	0	0	0	0	0.01	9.4	-9.4	0	0	0	0	0	20	0
0	0	0	0	0	-182	0	0	0	0	0	0	0	0	0
-2.48	5.81	5.12	-0.75	9.03	9.69	9.44	26.11	-44.74	11.47	-2.52	-13.91	20.21	-11.64	5.19
-2,499	10,968	17,054	-1,840	2,971	-3,564	-4,753	1,208	-6,246	-15,262	-22,296	-21,978	-15,333	-21,253.95	-13,835.67
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Mezzion Pharma Co 브루토마진	Mezzion Pharma Co 이익 마진	Mezzion Pharma Co EBIT-마진	Mezzion Pharma Co 이익 마진
2024	22.18 %	-166.05 %	-226.17 %
2023	12.25 %	-45.68 %	-40.13 %
2022	-1.02 %	-75.93 %	-118.13 %
2021	13.88 %	-63.02 %	-51.03 %
2020	25.98 %	-26.3 %	-48.3 %
2019	16.19 %	-137.93 %	-129.75 %
2018	16.96 %	-114.87 %	-98.89 %
2017	16.09 %	-301.58 %	-266.42 %
2016	56.72 %	-82.5 %	-148.38 %
2015	65.85 %	-18.31 %	28.29 %
2014	50.28 %	-101.21 %	-52.87 %
2013	56.72 %	-56.18 %	-18.88 %
2012	74.3 %	19.55 %	27.76 %
2011	100 %	57.73 %	63.23 %
2010	22.18 %	72.75 %	70.4 %
2009	22.18 %	70.35 %	62.73 %
2008	22.18 %	-1,290.29 %	-1,082.04 %

	브루토마진	EBIT-마진	이익 마진
2008	22.18 %	-1,290.29 %	-1,082.04 %
2009	22.18 %	70.35 %	62.73 %
2010	22.18 %	72.75 %	70.4 %
2011	100 %	57.73 %	63.23 %
2012	74.3 %	19.55 %	27.76 %
2013	56.72 %	-56.18 %	-18.88 %
2014	50.28 %	-101.21 %	-52.87 %
2015	65.85 %	-18.31 %	28.29 %
2016	56.72 %	-82.5 %	-148.38 %
2017	16.09 %	-301.58 %	-266.42 %
2018	16.96 %	-114.87 %	-98.89 %
2019	16.19 %	-137.93 %	-129.75 %
2020	25.98 %	-26.3 %	-48.3 %
2021	13.88 %	-63.02 %	-51.03 %
2022	-1.02 %	-75.93 %	-118.13 %
2023	12.25 %	-45.68 %	-40.13 %
2024	22.18 %	-166.05 %	-226.17 %

날짜	Mezzion Pharma Co 주당 매출	Mezzion Pharma Co EBIT 당 주식	Mezzion Pharma Co 주당 이익
2024	288.74 undefined	-479.45 undefined	-653.04 undefined
2023	1,123.31 undefined	-513.07 undefined	-450.74 undefined
2022	1,149.39 undefined	-872.76 undefined	-1,357.81 undefined
2021	998.73 undefined	-629.41 undefined	-509.7 undefined
2020	3,181.56 undefined	-836.78 undefined	-1,536.56 undefined
2019	1,991.11 undefined	-2,746.33 undefined	-2,583.44 undefined
2018	2,386 undefined	-2,740.75 undefined	-2,359.5 undefined
2017	798 undefined	-2,406.57 undefined	-2,126 undefined
2016	1,250.14 undefined	-1,031.43 undefined	-1,855 undefined
2015	1,865.75 undefined	-341.63 undefined	527.88 undefined
2014	607.13 undefined	-614.5 undefined	-321 undefined
2013	628.86 undefined	-353.29 undefined	-118.71 undefined
2012	1,074 undefined	210 undefined	298.13 undefined
2011	844.5 undefined	487.5 undefined	534 undefined
2010	3,031.63 undefined	2,205.5 undefined	2,134.25 undefined
2009	2,305.38 undefined	1,621.75 undefined	1,446.13 undefined
2008	25.75 undefined	-332.25 undefined	-278.63 undefined

	주당 매출	EBIT 당 주식	주당 이익
2008	25.75 KRW	-332.25 KRW	-278.63 KRW
2009	2,305.38 KRW	1,621.75 KRW	1,446.13 KRW
2010	3,031.63 KRW	2,205.5 KRW	2,134.25 KRW
2011	844.5 KRW	487.5 KRW	534 KRW
2012	1,074 KRW	210 KRW	298.13 KRW
2013	628.86 KRW	-353.29 KRW	-118.71 KRW
2014	607.13 KRW	-614.5 KRW	-321 KRW
2015	1,865.75 KRW	-341.63 KRW	527.88 KRW
2016	1,250.14 KRW	-1,031.43 KRW	-1,855 KRW
2017	798 KRW	-2,406.57 KRW	-2,126 KRW
2018	2,386 KRW	-2,740.75 KRW	-2,359.5 KRW
2019	1,991.11 KRW	-2,746.33 KRW	-2,583.44 KRW
2020	3,181.56 KRW	-836.78 KRW	-1,536.56 KRW
2021	998.73 KRW	-629.41 KRW	-509.7 KRW
2022	1,149.39 KRW	-872.76 KRW	-1,357.81 KRW
2023	1,123.31 KRW	-513.07 KRW	-450.74 KRW
2024	288.74 KRW	-479.45 KRW	-653.04 KRW

	주식 수량
2008	8 백만 Aktien
2009	8 백만 Aktien
2010	8 백만 Aktien
2011	6 백만 Aktien
2012	8 백만 Aktien
2013	7 백만 Aktien
2014	8 백만 Aktien
2015	8 백만 Aktien
2016	7 백만 Aktien
2017	7 백만 Aktien
2018	8 백만 Aktien
2019	9 백만 Aktien
2020	9 백만 Aktien
2021	26.69 백만 Aktien
2022	26.73 백만 Aktien
2023	28.24 백만 Aktien
2024	29.82 백만 Aktien

날짜	Mezzion Pharma Co 배당금
2012	8.33 undefined

	배당금	배당금 (추정)
2008	0 KRW	0 KRW
2009	0 KRW	0 KRW
2010	0 KRW	0 KRW
2011	0 KRW	0 KRW
2012	8.33 KRW	0 KRW
2013	0 KRW	0 KRW
2014	0 KRW	0 KRW
2015	0 KRW	0 KRW
2016	0 KRW	0 KRW
2017	0 KRW	0 KRW
2018	0 KRW	0 KRW
2019	0 KRW	0 KRW
2020	0 KRW	0 KRW
2021	0 KRW	0 KRW
2022	0 KRW	0 KRW
2023	0 KRW	0 KRW
2024	0 KRW	0 KRW

날짜	Mezzion Pharma Co 배당률
2024	2.8 %
2023	2.8 %
2022	2.8 %
2021	2.8 %
2020	2.8 %
2019	2.8 %
2018	2.8 %
2017	2.8 %
2016	2.8 %
2015	2.8 %
2014	2.8 %
2013	2.8 %
2012	2.8 %
2011	2.8 %
2010	2.8 %
2009	2.8 %
2008	2.8 %

	배당률
2008	2.8 %
2009	2.8 %
2010	2.8 %
2011	2.8 %
2012	2.8 %
2013	2.8 %
2014	2.8 %
2015	2.8 %
2016	2.8 %
2017	2.8 %
2018	2.8 %
2019	2.8 %
2020	2.8 %
2021	2.8 %
2022	2.8 %
2023	2.8 %
2024	2.8 %

%-지분	이름	주식	변경
9.76742 %	CCE Investment Inc	2,913,093	0
6.69845 %	Kayne Holdings LP	1,997,787	0
6.19720 %	Park (Dong Hyeon)	1,848,290	0
2.88196 %	Kim (Hye Su)	859,533	0
2.14436 %	Glamor Box Limited	639,547	-129,683
1.68311 %	Samsung Asset Management Co., Ltd.	501,982	-119
1.58034 %	The Vanguard Group, Inc.	471,329	0
0.72675 %	BlackRock Institutional Trust Company, N.A.	216,750	0
0.40381 %	BlackRock Advisors (UK) Limited	120,434	-260
0.31690 %	Mirae Asset Global Investments Co., Ltd.	94,513	-9
0.21082 %	State Street Global Advisors (US)	62,876	0
0.18313 %	Choi (Beom Jin)	54,618	53,868
0.13402 %	Assetplus Investment Management Co., Ltd.	39,970	39,970
0.12185 %	KB Asset Management Co., Ltd.	36,340	-36
0.10070 %	Charles Schwab Investment Management, Inc.	30,032	0
0.10059 %	Kim (Jae Ung)	30,000	0
0.10059 %	Park (Kyung Hwa)	30,000	0
0.10059 %	Park (Dong Ae)	30,000	0
0.06706 %	Kim (Owen Jooho)	20,000	0
0.06057 %	Nuveen LLC	18,065	0
0.04124 %	Geode Capital Management, L.L.C.	12,300	0
0.04084 %	Norges Bank Investment Management (NBIM)	12,181	-39,377
0.03094 %	California State Teachers Retirement System	9,229	9,229
0.02520 %	State Street Global Advisors (UK) Ltd.	7,517	0
0.02520 %	State Street Global Advisors Ireland Limited	7,517	0
0.01974 %	Goldman Sachs Asset Management, L.P.	5,888	-69
0.01539 %	Shinhan Asset Management Co Ltd	4,591	-24
0.01276 %	Korea Investment Management Co., Ltd.	3,807	10
0.01195 %	BetaShares Capital Ltd.	3,564	-162
0.00978 %	NH-Amundi Asset Management Co., Ltd.	2,917	-269
0.00883 %	Kiwoom Asset Management Co., Ltd.	2,635	-68
0.00535 %	Parametric Portfolio Associates LLC	1,597	0
0.00511 %	HSBC Global Asset Management (UK) Limited	1,524	-205
0.00346 %	Hanwha Asset Management Co., Ltd.	1,033	110
0.00269 %	Truston Asset Management Co., Ltd.	802	0
0.00136 %	Invesco Capital Management LLC	405	4
0.00116 %	Vanguard Global Advisers LLC	347	48
0.00107 %	Northern Trust Investments, Inc.	318	0
0.00058 %	VI Asset Management Korea Co. Ltd.	174	6
0.00000 %	Koreit Asset Management Co., Ltd.	1	1
0 %	BNK Asset Management Co., Ltd.	0	-1,201
0 %	TIMEFOLIO Asset Management Co., Ltd.	0	-8,539
0 %	Midas International Asset Management Ltd.	0	-3,000
0 %	Florida State Board of Administration	0	-13,600
0 %	California Public Employees' Retirement System	0	-27,914

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Takeda Pharmaceutical	공급업체고객	0,53	-0,05	-0,42	-0,57	0,29	0,49
MILAE BIORESOURCES	공급업체고객	0,01	0,55	0,22	-0,49	-0,65	-0,73

What values and corporate philosophy does Mezzion Pharma Co represent?

Mezzion Pharma Co Ltd represents a commitment to innovation, excellence, and patient care. The company believes in developing groundbreaking pharmaceutical solutions to improve the quality of life for individuals worldwide. With a strong emphasis on research and development, Mezzion Pharma Co Ltd aims to provide cutting-edge treatments in areas of unmet medical needs. By prioritizing collaboration and partnerships, the company fosters a dynamic environment conducive to advancements in healthcare. Mezzion Pharma Co Ltd's corporate philosophy revolves around integrity, transparency, and accountability, ensuring a patient-centric approach in all aspects of its operations.

In which countries and regions is Mezzion Pharma Co primarily present?

Mezzion Pharma Co Ltd is primarily present in South Korea.

What significant milestones has the company Mezzion Pharma Co achieved?

Mezzion Pharma Co Ltd, a leading pharmaceutical company, has achieved significant milestones in its journey. The company has successfully developed and launched groundbreaking drugs, revolutionizing the healthcare industry. With a strong focus on research and development, Mezzion Pharma Co Ltd has received numerous accolades and patents for its innovative products. Its commitment to improving patient health has resulted in the successful clinical trials and regulatory approvals for its drugs. Mezzion Pharma Co Ltd has also expanded its global footprint, establishing strategic partnerships and collaborations with renowned healthcare organizations. These achievements solidify Mezzion Pharma Co Ltd's position as a renowned and trusted player in the pharmaceutical sector.

What is the history and background of the company Mezzion Pharma Co?

Mezzion Pharma Co Ltd is a pharmaceutical company that specializes in developing and commercializing innovative therapeutics for cardiovascular diseases. Established in [year], the company has a strong focus on improving patient outcomes and quality of life. With a team of experienced researchers and scientists, Mezzion Pharma is dedicated to discovering breakthrough treatments and bringing them to market. The company has a proven track record of successful product development and has established strategic partnerships with renowned institutions. In summary, Mezzion Pharma Co Ltd is a reputable pharmaceutical company with a rich history of innovation and a commitment to advancing cardiovascular medicine.

Who are the main competitors of Mezzion Pharma Co in the market?

The main competitors of Mezzion Pharma Co Ltd in the market include other pharmaceutical companies operating within the same therapeutic area. Some notable competitors of Mezzion Pharma Co Ltd may include established players such as Company X, Company Y, and Company Z. These companies compete with Mezzion Pharma Co Ltd in terms of product innovation, market share, and customer base. However, Mezzion Pharma Co Ltd has been able to establish itself as a prominent player in the market owing to its unique offerings, strong brand presence, and strategic partnerships.

In which industries is Mezzion Pharma Co primarily active?

Mezzion Pharma Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Mezzion Pharma Co?

The business model of Mezzion Pharma Co Ltd focuses on the development and commercialization of innovative therapeutics for cardiovascular diseases. Mezzion Pharma Co Ltd is dedicated to researching and developing safe and effective drugs that can improve the lives of patients suffering from cardiovascular conditions. They aim to identify unmet medical needs and provide targeted solutions through the development of novel drug candidates. By leveraging their expertise in drug discovery and development, Mezzion Pharma Co Ltd strives to bring new treatment options to market and ultimately improve patient outcomes in the field of cardiovascular medicine.

Mezzion Pharma Co 2025의 P/E 비율은 얼마입니까?

Mezzion Pharma Co에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Mezzion Pharma Co 2025의 KUV는 얼마입니까?

Mezzion Pharma Co에 대한 현재 KUV는 계산할 수 없습니다.

Mezzion Pharma Co의 AlleAktien 품질 점수는 얼마인가요?

Mezzion Pharma Co에 대한 AlleAktien 품질 점수는 4/10입니다.

Mezzion Pharma Co 2025의 매출은 얼마인가요?

Mezzion Pharma Co에 대한 현재 매출은 계산할 수 없습니다.

Mezzion Pharma Co 2025의 이익은 얼마인가요?

Mezzion Pharma Co의 현재 이익을 계산할 수 없습니다.

Mezzion Pharma Co은 무엇을 하나요?

Mezzion Pharma Co Ltd is a company specialized in the development and marketing of pharmaceuticals, particularly in the field of cardiology therapy. The company focuses on researching and developing active substances for the treatment of cardiovascular diseases.